| Net income | 4.2M |
| Depreciation and amortization | |
| Share-based compensation | 77K |
| Realized gain on securities | 120K |
| Income tax receivable | 49K |
| Tax liabilities | -285K |
| Effects of liquidation of subsidiary | |
| Trade accounts receivables | 382K |
| Prepaid expenses and other assets | 41K |
| Accounts payable | |
| Accrued product licensing costs | -173K |
| Deferred revenue | |
| Income taxes payable | |
| Other liabilities | -1.31M |
| Net cash provided by operating activities | -482K |
| Purchases of marketable securities | -5.04M |
| Proceeds from sale of securities | 9.3M |
| Net cash provided (used in) by investing activities | 4.55M |
| Purchase of employee stock option | |
| Proceeds from exercise of common stock options | 0 |
| Net cash provided by financing activities | -444K |
| Net increase in cash and cash equivalents | 3.63M |
| Cash and cash equivalents, beginning of period | 7.96M |
| Cash and cash equivalents, end of period | 11.59M |